Bristol-Myers Squibb Co. says it will expand its presence in research centers in Cambridge, Massachusetts, and San Francisco, while cutting jobs in Connecticut.
The biopharmaceutical company announced Thursday it will open a research site in Cambridge - home to the Massachusetts Institute of Technology and Harvard - in 2018 and expand its research site in San Francisco. The expansion is expected to be completed next year.
In Cambridge, Bristol-Myers Squibb scientists will focus on efforts to make discoveries in genetically defined diseases, molecular discovery technologies and discovery platform chemistry.
It will relocate up to 200 workers from its Wallingford, Connecticut, and Waltham, Massachusetts, sites and a limited number from New Jersey. Of 900 jobs in Connecticut, 500 will remain at a different site to be determined and 100 jobs will be cut.